Stepped care to improve depression and anxiety in cancer patients.

• Conditions: Head and neck neoplasms; psycho-oncologyHoofd-halskanker; longkanker; angst; depressie; lung neoplasms; anxiety; depression; psycho-oncology

• Registration Number: NL-OMON26555
• Lead Sponsor: VUmc

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 176

Inclusion Criteria

1. Treatment for UICC stage I-IV lung or head and neck carcinoma: ICD-10 C00-C14 (lip, oral cavity and pharynx), C32 (larynx), C33 (trachea), C34 (lung);

2. Depression (minor or major) or (generalized) anxiety disorder as assessed by the Composite International Diagnostic Interview (CIDI).

Exclusion Criteria

1. Other (neurological) diseases causing cognitive dysfunction;

2. No motivation to undergo psychosocial therapy;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome is the Hospital Anxiety and Depression Scale (HADS).

Secondary Outcome Measures

Name	Time	Method
Secondary outcome measures are quality of life questionnaires (EORTC QLQ-C30, EORTC QLQ-HN35, EORTC QLQ-LC13), patient satisfaction with care (EORTC QLQ-PATSAT), and costs (health care utilization and work loss (TIC-P and PRODISQ modules)).<br>